Results 161 to 170 of about 9,273,634 (241)
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens +6 more
wiley +1 more source
Accelerated Preoperative Wound Bed Preparation Using Negative Pressure Wound Therapy With Instillation and Dwell Time: A Comparison With Conventional Negative Pressure Wound Therapy in Necrotic Wounds. [PDF]
Ohura N +6 more
europepmc +1 more source
Продолжува здружувањето на големите
изваР...
информатика, МЕДИС -
core
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur +11 more
wiley +1 more source
Dirofilaria asiatica Infection and Asymptomatic Microfilaremia, Sri Lanka, 2025. [PDF]
Mataraarachchi D +11 more
europepmc +1 more source
Содржина, ноември - декември, 1995, волумен 2, број 19
ИзваР...
информатика, МЕДИС -
core
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington +10 more
wiley +1 more source
Cascade Desolvation and Conversion Reaction Driven by Self-Tandem Catalysis for Wide-Temperature Li-S Batteries. [PDF]
Zhang J +10 more
europepmc +1 more source
Замена на делови од човечко тело Ñо вештачки делови
ИзваР...
информатика, МЕДИС -
core
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq +8 more
wiley +1 more source

